No Data
No Data
No Data
No Data
No Data
New Studies Prove the Clinical Benefits of Daxor's Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion
Data Presented at the American College of Cardiology Scientific Sessions; Research Letter Published in the Prestigious American Heart Journal Oak Ridge, TN, April 16, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation
GlobeNewswireApr 16 20:00
Daxor's Promising Growth and Innovation Outlook Merit a Buy Rating
TipRanksApr 15 17:17
Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital
450-Bed Hospital Purchases BVA-100 Blood Volume Analyzer to Launch Heart Failure Program Oak Ridge, TN, April 10, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood
GlobeNewswireApr 10 20:00
Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24
Oak Ridge, TN, April 01, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the American Col
GlobeNewswireApr 1 20:00
Daxor Corporation (NASDAQ:DXR) Q4 2023 Earnings Call Transcript
Yahoo FinanceMar 28 22:38
Daxor(DXR.US) Officer Buys US$6,525 in Common Stock
$Daxor(DXR.US)$ Officer Michel Robert J purchased 750 shares of Common Stock on Mar 27, 2024 at an average price of $8.7 for a total value of $6,525.Source: Announcement What is statement of changes i
Futu NewsMar 28 02:20
No Data
No Data